• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Amicus Therapeutics Inc

+ Add to Watchlist

FOLD:US

5.9400 USD 0.1300 2.24%

As of 20:10:00 ET on 10/24/2014.

Company Profile for Amicus Therapeutics Inc (FOLD)

Amicus Therapeutics, Inc. is a biopharmaceutical company that develops orally-administered, small molecule drugs to treat human genetic diseases. The drugs, called pharmacological chaperones, are being developed to treat Fabray, Gaucher, and Pompe disease.

Contact Information

Amicus Therapeutics Inc

6 Cedar Brook Drive
Cranbury, NJ 08512
United States
Phone: 1-609-662-2000

Key Executives for Amicus Therapeutics Inc (FOLD)

John F CrowleyChairman/CEOWilliam D Baird III "Chip"Chief Financial Officer
Bradley L CampbellChief Operating OfficerJay BarthChief Medical Ofcr
Hung DoSenior VP:Discovery BiologyPeter M MacalusoVP/Secretary/Counsel
Daphne QuimiVP:Finance/ControllerJohn R KirkVP:Regulatory Affairs
Ken ValenzanoVP:PharmacologyKenneth W PeistVP:Intellectual Property
Enrique DiloneVP:Technical OperationsJeffrey P CastelliVP:Program
Julie YuVP:Clinical OperationsJayne GershkowitzVP:Patient Advocacy
Sara PellegrinoDirector:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil